Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancer. [electronic resource]
Producer: 20030410Description: 1125-32 p. digitalISSN:- 0732-183X
- Administration, Oral
- Adult
- Aged
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- administration & dosage
- Colonic Neoplasms -- blood
- Cyclosporine -- administration & dosage
- Drug Resistance, Neoplasm
- Female
- Fluorouracil -- pharmacology
- Humans
- Infusions, Intravenous
- Irinotecan
- Male
- Middle Aged
- Neoplasm Staging
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.